Press "Enter" to skip to content

New patent for Astrazeneca Ab drug FARXIGA

0
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Ab drug FARXIGA

Annual Drug Patent Expirations for FARXIGA
Annual Drug Patent Expirations for FARXIGA

Farxiga is a drug marketed by Astrazeneca Ab
and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.

This drug has two hundred and eigthy-six patent family members in forty-four countries.

The generic ingredient in FARXIGA is dapagliflozin propanediol. One supplier is listed for this compound. Additional details are available on the dapagliflozin propanediol profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Ab drug FARXIGA
Do NOT follow this link or you will be banned from the site!